Plus Therapeutics Inc Cash Flow Reinvestment Rate
Latest as of December 2019:
2.75x
Plus Therapeutics Inc cash flow reinvestment rate. Plus Therapeutics Inc (PSTV) has a Cash Flow Reinvestment Rate of 2.75x as of December 2019, reinvesting $2.85 Million (capex $59.00K plus investments $2.79 Million) from operating cash flow of $1.04 Million. Explore Plus Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
2.75x
(Capex + Investments) / Operating CF
Total Reinvested
$2.85 Million
Capex + Investments
Operating Cash Flow
$1.04 Million
USD
Capital Expenditures
$59.00K
USD
Plus Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)
Plus Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Plus Therapeutics Inc. For the full cash flow conversion analysis, see Plus Therapeutics Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow